Niva Bupa Secures SEBI Approval for ₹3,000 Crore IPO

Private equity firm True North-backed Niva Bupa Health Insurance Ltd has received the green light from the Securities and Exchange Board of India (SEBI) to raise up to ₹3000 crore through an initial public offering (IPO). The company, formerly known as Max Bupa, plans to utilize the proceeds to strengthen its capital base and support general corporate activities.

Niva Bupa IPO comprises a fresh issue of ₹800 crore and an offer for sale of up to ₹2280 crore by existing shareholders and is expected to be one of the largest in the Indian health insurance sector. The book-running lead managers for the offering are ICICI Securities, Morgan Stanley, Kotak Mahindra Capital, Axis Capital, HDFC Bank, and Motilal Oswal.

About Niva Bupa

Niva Bupa is a leading standalone health insurer in India, offering a comprehensive range of health insurance products and services. With a strong focus on digital innovation, the company has been rapidly gaining market share. Its products and services provide customers with access to a wide network of healthcare providers and streamlined claims processes.

Key Highlights of Niva Bupa Include

• Market Leadership: Niva Bupa is one of India’s largest and fastest-growing standalone health insurers, with a Gross Direct Written Premium (GDPI) of ₹5,499.43 crore in Fiscal 2024.
• Digital-First Approach: The company leverages technology to enhance customer experience, from onboarding to claims settlement.
• Strong Financial Performance: Niva Bupa has consistently demonstrated robust financial growth, with its overall GWP and retail health GWP growing at CAGRs of 41.27% and 33.41%, respectively, between Fiscal 2022 and 2024.
• Customer Focus: The company prioritizes customer satisfaction, evidenced by its high claims settlement ratio and efficient claims processing.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.